Article (Scientific journals)
Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative beta-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability.
Paquet, Philippe; Jacob, Eric; Damas, Pierre et al.
2002In Critical Care Medicine, 30 (11), p. 2580-3
Peer Reviewed verified by ORBi
 

Files


Full Text
RECURRENT FATAL.pdf
Author postprint (126.76 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Aged; Anti-Bacterial Agents/adverse effects/pharmacology; Cefotaxime/adverse effects/pharmacology; Drug Interactions; Epidermal Necrolysis, Toxic/etiology; Fatal Outcome; Female; Humans; Thienamycins/adverse effects/pharmacology
Abstract :
[en] OBJECTIVE: A series of antibiotics may be responsible for toxic epidermal necrolysis. We report two successive episodes of toxic epidermal necrolysis in the same patient. Drug imputability criteria designate a cross-reactivity between two antibiotics of different chemical classes but sharing the beta-lactam ring in common. DESIGN: Descriptive case report and review of the literature. SETTING: Medical intensive care unit in a university medical center. PATIENT AND MAIN RESULTS: A 75-yr-old woman developed a first episode of toxic epidermal necrolysis (involving 40% of the body surface) after intake of cefotaxime, a third-generation cephalosporin. Perfusions of high-dose immunoglobulins rapidly improved the lesions, followed by partial reepithelialization in 5 days. Sepsis required the administration of meropenem, which is a carbapenem antibiotic. The epidermal destruction immediately recurred, with extension to previously uninvolved skin areas and fatal consequences. CONCLUSIONS: The beta-lactam ring present in cephalosporins and carbapenems represents the putative chemical structure responsible for the presently reported cross-reactivity to two antibiotics of different classes. Drugs having any chemical similarity to the initial culprit compound should be strictly avoided when possible in the management of toxic epidermal necrolysis.
Disciplines :
Dermatology
Author, co-author :
Paquet, Philippe ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Jacob, Eric
Damas, Pierre ;  Centre Hospitalier Universitaire de Liège - CHU > Soins intensifs
Pierard, Gérald ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Language :
English
Title :
Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative beta-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability.
Publication date :
2002
Journal title :
Critical Care Medicine
ISSN :
0090-3493
eISSN :
1530-0293
Publisher :
Lippincott Williams & Wilkins, Philadelphia, United States - Pennsylvania
Volume :
30
Issue :
11
Pages :
2580-3
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 27 March 2009

Statistics


Number of views
75 (3 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
41
Scopus citations®
without self-citations
34
OpenCitations
 
26

Bibliography


Similar publications



Contact ORBi